Published in Proc Natl Acad Sci U S A on August 04, 2014
Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. Cell Mol Immunol (2014) 0.97
Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. J Virol (2014) 0.96
Human iPSC-derived hepatocyte-like cells support Plasmodium liver-stage infection in vitro. Stem Cell Reports (2015) 0.94
Antiviral therapies and prospects for a cure of chronic hepatitis B. Cold Spring Harb Perspect Med (2015) 0.93
Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. Proc Natl Acad Sci U S A (2015) 0.90
Modeling Dengue Virus-Hepatic Cell Interactions Using Human Pluripotent Stem Cell-Derived Hepatocyte-like Cells. Stem Cell Reports (2016) 0.90
Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact. Dig Dis Sci (2015) 0.81
Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure. Antiviral Res (2015) 0.80
The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection. PLoS One (2017) 0.79
Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. J Hepatol (2016) 0.78
Physiologically relevant human tissue models for infectious diseases. Drug Discov Today (2016) 0.77
Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes. J Virol (2015) 0.77
Restrictive influence of SAMHD1 on Hepatitis B Virus life cycle. Sci Rep (2016) 0.77
Experimental models of hepatitis B and C - new insights and progress. Nat Rev Gastroenterol Hepatol (2016) 0.76
Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection. Hepatology (2017) 0.75
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Sci Rep (2016) 0.75
Cell sources for in vitro human liver cell culture models. Exp Biol Med (Maywood) (2016) 0.75
Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection. Mediators Inflamm (2016) 0.75
Advances and Challenges in Studying Hepatitis B Virus In Vitro. Viruses (2016) 0.75
Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor. Biores Open Access (2016) 0.75
Clinical Trials in a Dish. Trends Pharmacol Sci (2016) 0.75
Productive Infection of Human Embryonic Stem Cell-Derived NKX2.1+ Respiratory Progenitors with Human Rhinovirus. Stem Cells Transl Med (2015) 0.75
Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection. Sci Rep (2017) 0.75
Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection. Viruses (2016) 0.75
Engineered Liver Platforms for Different Phases of Drug Development. Trends Biotechnol (2016) 0.75
Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res (2016) 0.75
Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems. Viruses (2015) 0.75
Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen. Viruses (2017) 0.75
Long-term hepatitis B infection in a scalable hepatic co-culture system. Nat Commun (2017) 0.75
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity. Immunity (2017) 0.75
The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32
Viral clearance without destruction of infected cells during acute HBV infection. Science (1999) 6.78
Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology (2010) 6.40
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science (2014) 5.47
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife (2012) 5.18
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem (2002) 3.50
Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 3.47
Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev (2000) 2.93
Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem (2005) 2.70
New insight in the pathobiology of hepatitis B virus infection. Gut (2012) 2.54
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44
Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature (2014) 2.23
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol (1988) 2.11
Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology (1993) 1.95
A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe (2013) 1.95
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut (2011) 1.78
HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development (2011) 1.50
Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol (2013) 1.49
Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro. Cell (1978) 1.44
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (2011) 1.42
Liver cell models in in vitro toxicology. Environ Health Perspect (1998) 1.42
Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv (2014) 1.33
Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog (2012) 1.29
Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology (2010) 1.14
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J Hepatol (2012) 1.11
Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4alpha. PLoS One (2009) 1.00
High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J Biol Chem (2001) 0.94
Distinct antiviral responses in pluripotent versus differentiated cells. PLoS Pathog (2014) 0.91
Innate response to hepatitis B virus infection: observations challenging the concept of a stealth virus. Hepatology (2009) 0.87
Evidence for IRF-1-dependent gene expression deficiency in interferon unresponsive HepG2 cells. Biochim Biophys Acta (1999) 0.87
Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver. J Virol (2014) 0.81